m6A介导的IGF1低甲基化损害了二分化并促进了孕前的发病:对表观遗传疗法的影响
Jing Tong1, Xingyun Yan2, Cong Zhang1
1Department of Reproductive Medicine, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cell biology international
|January 21, 2026
概括
在决定中中断的N6-甲基氨酸 (m6A) 甲基化会通过降低胰岛素样生长因子1 (IGF1) 的调节来损害妊娠维持,从而为孕前 (PE) 病原体提供了新的见解.
科学领域:
- 生殖生物学 生殖生物学
- 史诗转录组学 史诗转录组学
- 母胎界面 母胎界面
背景情况:
- 孕前炎症 (PE) 的发病过程涉及到母亲的乳腺组织.
- N6-甲基氨酸 (m6A) 是一个关键的表皮转录组修饰.
- 果功能障碍有助于PE的发展.
研究的目的:
- 为了研究m6A甲基化在PE患者的决定中的作用.
- 确定受m6A调节障碍影响的特定基因和途径.
- 阐明改变的m6A模式对决定化的功能影响.
主要方法:
- 甲基化RNA免疫沉降测序 (MeRIP-seq) 和RNA测序 (RNA-seq) 在早期发病的PE,晚期发病的PE和正常怀孕的脱落样本上进行.
- 对m6A甲基化和mRNA表达数据的综合分析.
- 在人类子宫内膜层细胞中进行定量PCR和siRNA敲除以进行验证.
主要成果:
- 不同地甲基化和表达的基因在决定化 (HIF-1,PI3K-AKT,Rap1信号传递) 关键的途径中得到了丰富.
- 在PE决定中,胰岛素类生长因子1 (IGF1) 被低甲基化并降低调节.
- 减少IGF1表达损害了叶标记,通过体外研究证实.
结论:
- 被破坏的m6甲基化通过PE的IGF1失调损害了决定化.
- 在母胎界面上,表皮转录体调节至关重要.
- m6A-修改的转录代表了PE的潜在治疗和诊断目标.
相关概念视频
01:46Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
01:37Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
02:40The Eukaryotic Promoter Region
18.7K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
00:59Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
01:23Cystic Fibrosis: Pathogenesis
738
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
738